These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35977831)

  • 1. Association of Blood Pressure Lowering Intensity With White Matter Network Integrity in Patients With Cerebral Small Vessel Disease.
    Pflanz CP; Egle MS; O'Brien JT; Morris RG; Barrick TR; Blamire AM; Ford GA; Tozer D; Markus HS;
    Neurology; 2022 Oct; 99(17):e1945-e1953. PubMed ID: 35977831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial.
    Croall ID; Tozer DJ; Moynihan B; Khan U; O'Brien JT; Morris RG; Cambridge VC; Barrick TR; Blamire AM; Ford GA; Markus HS;
    JAMA Neurol; 2018 Jun; 75(6):720-727. PubMed ID: 29507944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive change.
    Williams OA; Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Mackinnon AD; Morris RG; Markus HS; Charlton RA; Barrick TR
    Neuroimage Clin; 2017; 16():330-342. PubMed ID: 28861335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
    Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral small vessel disease: Recent advances and future directions.
    Markus HS; de Leeuw FE
    Int J Stroke; 2023 Jan; 18(1):4-14. PubMed ID: 36575578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease.
    Egle M; Hilal S; Tuladhar AM; Pirpamer L; Bell S; Hofer E; Duering M; Wason J; Morris RG; Dichgans M; Schmidt R; Tozer DJ; Barrick TR; Chen C; de Leeuw FE; Markus HS
    Neuroimage Clin; 2022; 35():103114. PubMed ID: 35908307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies.
    Croall ID; Lohner V; Moynihan B; Khan U; Hassan A; O'Brien JT; Morris RG; Tozer DJ; Cambridge VC; Harkness K; Werring DJ; Blamire AM; Ford GA; Barrick TR; Markus HS
    Clin Sci (Lond); 2017 Jun; 131(12):1361-1373. PubMed ID: 28487471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-shell Diffusion MRI Models for White Matter Characterization in Cerebral Small Vessel Disease.
    Konieczny MJ; Dewenter A; Ter Telgte A; Gesierich B; Wiegertjes K; Finsterwalder S; Kopczak A; Hübner M; Malik R; Tuladhar AM; Marques JP; Norris DG; Koch A; Dietrich O; Ewers M; Schmidt R; de Leeuw FE; Duering M
    Neurology; 2021 Feb; 96(5):e698-e708. PubMed ID: 33199431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter changes and gait decline in cerebral small vessel disease.
    van der Holst HM; Tuladhar AM; Zerbi V; van Uden IWM; de Laat KF; van Leijsen EMC; Ghafoorian M; Platel B; Bergkamp MI; van Norden AGW; Norris DG; van Dijk EJ; Kiliaan AJ; de Leeuw FE
    Neuroimage Clin; 2018; 17():731-738. PubMed ID: 29270357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rich-Club Analysis of the Structural Brain Network in Cases with Cerebral Small Vessel Disease and Depression Symptoms.
    Lu Y; Li Y; Feng Q; Shen R; Zhu H; Zhou H; Zhao Z
    Cerebrovasc Dis; 2022; 51(1):92-101. PubMed ID: 34537766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Rashid T; Li K; Toledo JB; Nasrallah I; Pajewski NM; Dolui S; Detre J; Wolk DA; Liu H; Heckbert SR; Bryan RN; Williamson J; Davatzikos C; Seshadri S; Launer LJ; Habes M
    JAMA Netw Open; 2023 Mar; 6(3):e231055. PubMed ID: 36857053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of white-matter mask selection on DTI histogram-based metrics as potential biomarkers in cerebral small vessel disease.
    Fouto AR; Nunes RG; Pinto J; Alves L; Calado S; Gonçalves C; Rebolo M; Viana-Baptista M; Vilela P; Figueiredo P
    MAGMA; 2022 Oct; 35(5):779-790. PubMed ID: 34997895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study.
    van Norden AG; de Laat KF; van Dijk EJ; van Uden IW; van Oudheusden LJ; Gons RA; Norris DG; Zwiers MP; de Leeuw FE
    Biochim Biophys Acta; 2012 Mar; 1822(3):401-7. PubMed ID: 21549191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials.
    Benjamin P; Zeestraten E; Lambert C; Ster IC; Williams OA; Lawrence AJ; Patel B; MacKinnon AD; Barrick TR; Markus HS
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):228-40. PubMed ID: 26036939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural brain network measures in elderly patients with cerebral small vessel disease and depressive symptoms.
    Gu Y; Zhao P; Feng W; Xia X; Tian X; Yan Y; Wang X; Gao D; Du Y; Li X
    BMC Geriatr; 2022 Jul; 22(1):568. PubMed ID: 35810313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural network connectivity impairment and depressive symptoms in cerebral small vessel disease.
    Xie X; Shi Y; Zhang J
    J Affect Disord; 2017 Oct; 220():8-14. PubMed ID: 28575716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in small-vessel disease relates to white matter ultrastructural damage, not disability.
    Brookes RL; Herbert V; Lawrence AJ; Morris RG; Markus HS
    Neurology; 2014 Oct; 83(16):1417-23. PubMed ID: 25230999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T
    Brandhofe A; Stratmann C; Schüre JR; Pilatus U; Hattingen E; Deichmann R; Nöth U; Wagner M; Gracien RM; Seiler A
    J Cereb Blood Flow Metab; 2021 Jul; 41(7):1767-1777. PubMed ID: 33327818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal decline in structural networks predicts dementia in cerebral small vessel disease.
    Lawrence AJ; Zeestraten EA; Benjamin P; Lambert CP; Morris RG; Barrick TR; Markus HS
    Neurology; 2018 May; 90(21):e1898-e1910. PubMed ID: 29695593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.